Smith and Richards Recap the FDA's Workshop on Troponin Assays in Regulatory Focus


Precision for Medicine’s Judi Smith and Karen Richards highlight key takeaways from the FDA’s Cardiac Troponin Assays workshop. They review the history, uses, and issues associated with measuring troponin and innovative medical devices to detect troponin levels as an assay to aid in diagnosis.

To read the article, please click here.

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.